The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)

Market Cap	10.82B +21.1%
Revenue (ttm)	13.42B +16.9%
Net Income	815.70M +37.4%
EPS	26.11 +37.4%
Shares Out	31.24M
PE Ratio	13.26
Forward PE	n/a
Dividend	6.40 (1.85%)
Ex-Dividend Date	Oct 27, 2025

Volume	186,644
Average Volume	115,203
Open	352.00
Previous Close	350.70
Day's Range	345.00 - 352.00
52-Week Range	273.80 - 371.00
Beta	0.18
RSI	60.22
Earnings Date	Jan 26, 2026

About DSE:IBNSINA

The IBN SINA Pharmaceutical Industry PLC produces and sells pharmaceutical drugs in Bangladesh and internationally. The company provides its products in various forms, such as solid dosage forms consisting of tablets and capsules; parenteral products covering ampoules and vials; liquid dosage forms comprising syrups, solutions, suspensions, and powder for suspension (dry syrups); and sterile ophthalmic products, creams, ointments, gels, eye drops and sachet, etc. It also offers various therapeutic products, including analgesic and anti-inflamma...

• Industry: Pharmaceutical Preparations
• Founded: 1983
• Employees: 5,200
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: IBNSINA

Financial Performance

In fiscal year 2025, DSE:IBNSINA's revenue was 11.88 billion, an increase of 4.51% compared to the previous year's 11.37 billion. Earnings were 633.19 million, a decrease of -5.57%.